SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%
Wed, 13 Feb

SUN PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m66,53269,37677,40211.6%16.3%
Other incomeRs m1,2923,5121,931-45.0%49.4%
TurnoverRs m67,82472,88879,3338.8%17.0%
ExpensesRs m51,99954,06455,8733.3%7.5%
Gross profitRs m14,5343,16821,529579.5%48.1%
DepreciationRs m3,3934,2654,71110.4%38.8%
InterestRs m9531,2951,44811.8%51.9%
Profit before taxRs m11,4791,11917,3011445.6%50.7%
TaxRs m7,4872,1892,70923.8%-63.8%
Profit after taxRs m3,992-1,07014,592265.5%
Gross profit margin%21.84.627.8
Effective tax rate%65.2195.615.7
Net profit margin%5.9-1.518.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 16.3% on a year-on-year (YoY) basis. The expenses were up by 7.5% YoY during the same period.
  • The company's operating profit increased by 48.1% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 3QFY19 as against 21.8% in 3QFY18.
  • Depreciation charges increased by 38.8% and finance costs increased by 51.9% YoY, respectively.
  • Other income increased by 49.4% YoY during the quarter.
  • Net profit for the quarter increased by 265.5% YoY. Net profit margins during the quarter increased from 5.9% in 3QFY18 to 18.4% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 11.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.3% QoQ during the same period.
  • The company's operating profit increased by 579.5% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 3QFY19 as against 4.6% in 2QFY18.
  • Net profit for the quarter increased by 1464.1% QoQ, while net profit margins increased from -1.5% in 2QFY18 to 18.4% in 3QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 589.4 to Rs 453.0, registering a Loss of Rs 136.4 or around 23.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,859.9 (up 0.7%). Over the last one year it has moved down from 14,517.2 to 13,859.9, a gain of 657 points (down 4.5%).

Overall, the S&P BSE SENSEX is up 5.8% over the year.

Current Valuations

At the current price of Rs 453.0, the price to earnings (P/E) ratio of SUN PHARMA stands at 27.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.9 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Protect Your Wealth from Fund Managers(Fast Profits Daily)

May 14, 2020

Do you know how much you are paying in fees to your mutual fund? In this video I'll share with you my views.

How Commodity Prices Tell You When Stocks Will Go Up(Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

Why Buffet - and you - should study Quantum Liquid Fund(The Honest Truth)

May 14, 2020

Ajit Dayal on how Quantum Liquid Fund and Warren Buffett have similar investing styles.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


May 26, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS